Patents by Inventor Angela ROMANELLI

Angela ROMANELLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATMENT USING ANTI-CD123 IMMUNOCONJUGATES
    Publication number: 20230312735
    Abstract: Methods of administering immunoconjugates that bind to CD123 are provided. The methods comprise administering an anti-CD123 immunoconjugate (e.g., IMGN632) to a subject in need thereof, for example, a patient with a hematologic malignancy, at a therapeutically effective dose regimen that results in treatment of the hematologic malignancy.
    Type: Application
    Filed: November 9, 2022
    Publication date: October 5, 2023
    Inventors: Patrick ZWEIDLER-MCKAY, Kerry CULM-MERDEK, Callum SLOSS, Angela ROMANELLI
  • ANTI-CD37 IMMUNOCONJUGATE AND ANTI-CD20 ANTIBODY COMBINATIONS
    Publication number: 20230190638
    Abstract: Methods of administering immunoconjugates that bind to CD37 (e.g., IMGN529) in combination with antibodies that bind to CD20 are provided. The methods comprise administering an anti-CD37 immunoconjugate (e.g., IMGN529) and an anti-CD20 antibody to a person in need thereof, for example, a cancer patient.
    Type: Application
    Filed: July 25, 2022
    Publication date: June 22, 2023
    Inventors: Angela ROMANELLI, Rodrigo R. RUIZ-SOTO, Jose PONTE, Jutta DECKERT, Jan PINKAS
  • Anti-CD37 immunoconjugate and anti-CD20 antibody combinations
    Patent number: 11395796
    Abstract: Methods of administering immunoconjugates that bind to CD37 (e.g., IMGN529) in combination with antibodies that bind to CD20 are provided. The methods comprise administering an anti-CD37 immunoconjugate (e.g., IMGN529) and an anti-CD20 antibody to a person in need thereof, for example, a cancer patient.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: July 26, 2022
    Assignee: Debiopharm International, S.A.
    Inventors: Angela Romanelli, Rodrigo R. Ruiz-Soto, Jose Ponte, Jutta Deckert, Jan Pinkas
  • Methods for improving anti-CD37 immunoconjugate therapy
    Patent number: 11278629
    Abstract: Methods for identifying and treating patients having cancer who are likely to respond to treatment with an anti-CD37 immunoconjugate (e.g., IMGN529) are provided.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: March 22, 2022
    Assignee: DEBIOPHARM INTERNATIONAL, S.A.
    Inventors: Francesco Bertoni, Angela Romanelli, Callum Sloss
  • METHODS OF TREATMENT USING ANTI-CD123 IMMUNOCONJUGATES
    Publication number: 20200157228
    Abstract: Methods of administering immunoconjugates that bind to CD123 are provided. The methods comprise administering an anti-CD123 immunoconjugate (e.g., IMGN632) to a subject in need thereof, for example, a patient with a hematologic malignancy, at a therapeutically effective dose regimen that results in treatment of the hematologic malignancy.
    Type: Application
    Filed: October 30, 2019
    Publication date: May 21, 2020
    Inventors: Patrick ZWEIDLER-MCKAY, Kerry CULM-MERDEK, Callum SLOSS, Angela ROMANELLI
  • METHODS FOR IMPROVING ANTI-CD37 IMMUNOCONJUGATE THERAPY
    Publication number: 20200054763
    Abstract: Methods for identifying and treating patients having cancer who are likely to respond to treatment with an anti-CD37 immunoconjugate (e.g., IMGN529) are provided.
    Type: Application
    Filed: November 2, 2017
    Publication date: February 20, 2020
    Inventors: Francesco BERTONI, Angela ROMANELLI, Callum SLOSS
  • ANTI-CD37 IMMUNOCONJUGATE AND ANTI-CD20 ANTIBODY COMBINATIONS
    Publication number: 20190183788
    Abstract: Methods of administering immunoconjugates that bind to CD37 (e.g., IMGN529) in combination with antibodies that bind to CD20 are provided. The methods comprise administering an anti-CD37 immunoconjugate (e.g., IMGN529) and an anti-CD20 antibody to a person in need thereof, for example, a cancer patient.
    Type: Application
    Filed: October 25, 2018
    Publication date: June 20, 2019
    Inventors: Angela Romanelli, Rodrigo R. Ruiz-Soto, Jose Ponte, Jutta Deckert, Jan Pinkas
  • ANTI-CD37 IMMUNOCONJUGATE AND ANTI-CD20 ANTIBODY COMBINATIONS
    Publication number: 20170000900
    Abstract: Methods of administering immunoconjugates that bind to CD37 (e.g., IMGN529) in combination with antibodies that bind to CD20 are provided. The methods comprise administering an anti-CD37 immunoconjugate (e.g., IMGN529) and an anti-CD20 antibody to a person in need thereof, for example, a cancer patient.
    Type: Application
    Filed: June 2, 2016
    Publication date: January 5, 2017
    Inventors: Angela ROMANELLI, Rodrigo R. RUIZ-SOTO, Jose PONTE, Jutta DECKERT, Jan PINKAS